0001315863-17-000342.txt : 20170410
0001315863-17-000342.hdr.sgml : 20170410
20170410132011
ACCESSION NUMBER: 0001315863-17-000342
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20170410
DATE AS OF CHANGE: 20170410
EFFECTIVENESS DATE: 20170410
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RPS BioPharma Holdings, LP
CENTRAL INDEX KEY: 0001702585
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-284413
FILM NUMBER: 17752675
BUSINESS ADDRESS:
STREET 1: 190 ELGIN AVENUE
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
BUSINESS PHONE: 212-883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
D
1
primary_doc.xml
X0707
D
LIVE
0001702585
RPS BioPharma Holdings, LP
27 HOSPITAL ROAD
GEORGE TOWN
E9
CAYMAN ISLANDS
KY1-9008
212-883-0200
CAYMAN ISLANDS
None
None
Other
a Cayman Islands exempted limited partnership
true
2016
Pablo
Legorreta
110 East 59th Street
33rd Floor
New York
NY
NEW YORK
10022
Director
Director of the General Partner
Rory
Riggs
110 East 59th Street
33rd Floor
New York
NY
NEW YORK
10022
Director
Director of the General Partner
N/A
Pharma Management (Cayman) Ltd.
27 Hospital Road
George Town
E9
CAYMAN ISLANDS
KY1-9008
Promoter
Pharma Management (Cayman) Ltd. is the General Partner of the Issuer
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
2017-03-27
false
true
true
true
Structured in part as a business combination (exchange offer).
100000
Indefinite
149581598
Indefinite
false
21
0
0
0
false
RPS BioPharma Holdings, LP
/s/Pablo Legorreta
Pablo Legorreta
Director of the General Partner
2017-04-10